Atlas Trials

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Clinical trial NCT06156410 · RECRUITING

Trial details

NCT number
NCT06156410
Sponsor
Children's Hospital of Philadelphia
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ewing SarcomaOsteosarcomaSarcomas
Start date
2023-10-24
Primary completion
2027-11-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.